Section Arrow
SOLV.NYSE
- Solventum Corp
Quotes are at least 15-min delayed:2025/09/16 23:16 EDT
Regular Hours
Last
 74.13
+0.92 (+1.26%)
Day High 
74.35 
Prev. Close
73.21 
1-M High
75.6 
Volume 
1.01M 
Bid
71
Ask
77
Day Low
73.105 
Open
73.28 
1-M Low
70.275 
Market Cap 
12.69B 
Currency USD 
P/E 33.58 
%Yield -- 
10-SMA 72.74 
20-SMA 72.66 
50-SMA 73.09 
52-W High 85.92 
52-W Low 60.7 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.18/6.15
Enterprise Value
20.50B
Balance Sheet
Book Value Per Share
21.02
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
8.25B
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BNGOBionano Genomics Inc1.78-0.99-35.74%0.02PE
HBIOHarvard Bioscience0.4849+0.0454+10.33%-- 
AVTRAvantor12.71+0.32+2.58%12.27PE
BAXBaxter International23.87+0.07+0.29%140.32PE
MBOTMicrobot Medical3.34-0.08-2.34%-- 
Quotes are at least 15-min delayed:2025/09/16 23:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.